PhRMA, the Partnership for Safe Medicines and the Council for Affordable Health Coverage filed a complaint in the U.S. District Court for the District of Columbia challenging a final rule issued by the U.S. Department of Health and Human Services and Food and Drug Administration permitting pharmacists and wholesalers to import certain prescription drugs from Canada into the United States without drug manufacturers’ authorization or oversight (85 Fed. Reg. 62,094 Oct. 1, 2020).